Melody transcatheter valve: Histopathology and clinical implications of nine explanted devices. (15th June 2015)

• Record Type: Journal Article
• Authors: Schneider, Heike; Vogt, Manfred; Boekenkamp, Regina; Hoerer, Juergen; Eicken, Andreas; Foth, Rudi; Kriebel, Thomas; Paul, Thomas; Sigler, Matthias
• Is Part Of: International journal of cardiology. Volume 189(2015)
• Page Start: 124
• Page End: 131
• Publication Date: 2015-06-15
• Subjects: Catheterization -- Congenital heart defects -- Histopathology -- Implantable heart valves; Cardiology -- Periodicals; Electronic journals; 616.12
• DOI: 10.1016/j.ijcard.2015.04.067
• Languages: English
• ISSNs: 0167-5273

Abstract

Abstract: Objectives: We examined interventionally implanted valved Melody conduits after surgical explantation by means of histology and immunohistochemistry and matched these findings with clinical data in order to assess in vivo biocompatibility and to identify risk factors for graft failure. Methods: 9 Melody valves had been implanted in 8 patients (pulmonary n = 7, tricuspid position n = 1). Indication for explantation included significant obstruction in 7 patients and valve insufficiency in 1 patient. 4 of 8 patients had suffered from endocarditis. Mean interval between implantation and explantation was 3.2 (1.8–5.2) years. All explants were worked up using a uniform protocol with fixation in formalin and embedding in methylmethacrylate. Results: All but one valve of the explanted Melody grafts were thin and histologically intact without any pathological findings. Complete neo-endothelialization could be demonstrated by means of immunohistochemistry. All 4 Melody valves from patients with endocarditis showed dense granulocytic infiltrations, 3 of these showed thrombotic material within the valves. Conclusion: This report covers the first series of explanted Melody valves from humans applying a uniform protocol for histopathological examination. Good biocompatibility of the Melody valves could be demonstrated after a mid-term follow-up. Factors for graft failure included endocarditis, outgrowth, and residual stenosis. These findings may have significant implications for the implant procedure as well as care of the patients during long-term follow-up.